# Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes

> **NCT00110370** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 300 (—)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Lispro Mixture Therapy
- **DRUG:** Glargine Basal-Bolus Therapy

## Key facts

- **NCT ID:** NCT00110370
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 300 (—)
- **Last updated:** 2007-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00110370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00110370, "Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00110370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*